Nikhil H. Ramaiya

Crizotinib in<i>ALK</i>-Rearranged Inflammatory Myofibroblastic Tumor

James E. Butrynski, David R. D’Adamo, Jason L. Hornick et al. · New England Journal of Medicine · 2010 · 867 citations

Veterinary Medicine, Cancer Biology, Oncology +17

Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients

F. Stephen Hodi, Marcus O. Butler, Darryl A. Oble et al. · Proceedings of the National Academy of Sciences · 2008 · 648 citations · Full text

Medicine, Immunology, Oncology +17

Bevacizumab plus Ipilimumab in Patients with Metastatic Melanoma

F. Stephen Hodi, Donald P. Lawrence, Cecilia Lezcano et al. · Cancer Immunology Research · 2014 · 604 citations · Full text

Pharmacy, Immunology, Pharmacology +16

Developing a Common Language for Tumor Response to Immunotherapy: Immune-Related Response Criteria Using Unidimensional Measurements

Mizuki Nishino, Anita Giobbie‐Hurder, Maria Gargano et al. · Clinical Cancer Research · 2013 · 522 citations · Full text

Medicine, Immunology, Oncology +15

PD-1 Inhibitor–Related Pneumonitis in Advanced Cancer Patients: Radiographic Patterns and Clinical Course

Mizuki Nishino, Nikhil H. Ramaiya, Mark M. Awad et al. · Clinical Cancer Research · 2016 · 494 citations · Full text

Medicine, Oncology, Pharmacotherapy +17